Ilika (LON:IKA) Shares Pass Below Two Hundred Day Moving Average - Should You Sell?

Key Points

• Ilika shares fell below their 200‑day moving average, trading as low as GBX 29 (200‑day MA GBX 38.47) and down about 1.7% on a volume of ~43,256 shares.
• Business and fundamentals: Ilika is a small‑cap (~£52.4m) pioneer in solid‑state batteries (Stereax micro batteries and Goliath large‑format cells) with a negative P/E (‑6.39), very high current/quick ratios but a high debt‑to‑equity (3.18), signaling strong liquidity yet notable leverage risk.

Shares of Ilika plc (LON:IKA - ) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 38.47 and traded as low as GBX 29. Ilika shares last traded at GBX 29, with a volume of 43,256 shares traded.

Ilika Stock Down 1.7%

The stock's fifty day moving average price is GBX 32.36 and its 200 day moving average price is GBX 38.47. The stock has a market cap of £52.44 million, a P/E ratio of -6.39 and a beta of 1.94. The company has a current ratio of 9.07, a quick ratio of 15.43 and a debt-to-equity ratio of 3.18.

About Ilika

Ilika plc LON: IKA is a pioneer in solid state battery technology with their innovative Stereax micro batteries designed for Industrial IoT and MedTech markets, and their Goliath large format batteries for the electric vehicle and consumer electronics markets. Ilika works closely with its ecosystem of partners to provide them with customisable Stereax micro batteries that provide the specific power requirements their IoT or MedTech application requires. Stereax battery technology offers compelling advantages over conventional lithium ion batteries, including smaller footprint, high energy density, non-toxic materials, faster charging, increased cycle life, low leakage and reduced flammability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.